Literature DB >> 28243754

Differentiation of atypical Parkinson syndromes.

Günter U Höglinger1,2, Jan Kassubek3, Ilona Csoti4, Reinhard Ehret5, Heinz Herbst6, Ingmar Wellach7, Jürgen Winkler8, Wolfgang H Jost9.   

Abstract

In distinction to idiopathic Parkinson's disease (PD), the diagnosis of atypical Parkinson syndromes comprises dementia with Lewy bodies (DLB), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). We set out to write a state-of-the-art guideline as to which investigations and examinations help to differentiate PD vs. atypical Parkinson syndromes in clinical routine.

Entities:  

Keywords:  Corticobasal degeneration; Dementia with Lewy bodies; Multiple system atrophy; Parkinson’s disease; Progressive supranuclear palsy

Mesh：

Year:  2017        PMID： 28243754     DOI： 10.1007/s00702-017-1700-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  53 in total

1.  Red flags for multiple system atrophy.

Authors:  Martin Köllensperger; Felix Geser; Klaus Seppi; Michaela Stampfer-Kountchev; Martin Sawires; Christoph Scherfler; Sylvia Boesch; Joerg Mueller; Vasiliki Koukouni; Niall Quinn; Maria Teresa Pellecchia; Paolo Barone; Nicole Schimke; Richard Dodel; Wolfgang Oertel; Erik Dupont; Karen Østergaard; Christine Daniels; Günther Deuschl; Tanya Gurevich; Nir Giladi; Miguel Coelho; Cristina Sampaio; Christer Nilsson; Håkan Widner; Francesca Del Sorbo; Alberto Albanese; Adriana Cardozo; Eduardo Tolosa; Michael Abele; Thomas Klockgether; Christoph Kamm; Thomas Gasser; Ruth Djaldetti; Carlo Colosimo; Giuseppe Meco; Anette Schrag; Werner Poewe; Gregor K Wenning
Journal:  Mov Disord       Date:  2008-06-15       Impact factor: 10.338

Review 2.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

Review 3.  Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.

Authors:  Benjamin Dehay; Mathieu Bourdenx; Philippe Gorry; Serge Przedborski; Miquel Vila; Stephane Hunot; Andrew Singleton; C Warren Olanow; Kalpana M Merchant; Erwan Bezard; Gregory A Petsko; Wassilios G Meissner
Journal:  Lancet Neurol       Date:  2015-06-03       Impact factor: 44.182

4.  Severity of orthostatic hypotension in the course of Parkinson's disease: no correlation with the duration of the disease.

Authors:  Wolfgang H Jost; Sarunas Augustis
Journal:  Parkinsonism Relat Disord       Date:  2014-12-24       Impact factor: 4.891

Review 5.  Vascular parkinsonism--characteristics, pathogenesis and treatment.

Authors:  Amos D Korczyn
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

6.  Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.

Authors:  Giovanni Rizzo; Paolo Martinelli; David Manners; Cesa Scaglione; Caterina Tonon; Pietro Cortelli; Emil Malucelli; Sabina Capellari; Claudia Testa; Piero Parchi; Pasquale Montagna; Bruno Barbiroli; Raffaele Lodi
Journal:  Brain       Date:  2008-09-26       Impact factor: 13.501

7.  Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification.

Authors:  Hans-Jürgen Huppertz; Leona Möller; Martin Südmeyer; Rüdiger Hilker; Elke Hattingen; Karl Egger; Florian Amtage; Gesine Respondek; Maria Stamelou; Alfons Schnitzler; Elmar H Pinkhardt; Wolfgang H Oertel; Susanne Knake; Jan Kassubek; Günter U Höglinger
Journal:  Mov Disord       Date:  2016-10       Impact factor: 10.338

Review 8.  A Review of Treatment Options for Progressive Supranuclear Palsy.

Authors:  Maria Stamelou; Günter Höglinger
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

9.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

10.  The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T.

Authors:  Stefan T Schwarz; Mohammed Afzal; Paul S Morgan; Nin Bajaj; Penny A Gowland; Dorothee P Auer
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240
View more
  13 in total

Review 1.  Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.

Authors:  Ralph Buchert; Carsten Buhmann; Ivayla Apostolova; Philipp T Meyer; Jürgen Gallinat
Journal:  Dtsch Arztebl Int       Date:  2019-11-01       Impact factor: 5.594

2.  The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care.

Authors:  Odette Fründt; Tina Mainka; Beate Schönwald; Bianca Müller; Polina Dicusar; Christian Gerloff; Carsten Buhmann
Journal:  J Neural Transm (Vienna)       Date:  2018-08-22       Impact factor: 3.575

3.  Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes.

Authors:  Martin Gorges; Melanie N Maier; Johannes Rosskopf; Olga Vintonyak; Elmar H Pinkhardt; Albert C Ludolph; Hans-Peter Müller; Jan Kassubek
Journal:  J Neurol       Date:  2017-07-31       Impact factor: 4.849

Review 4.  Can Autonomic Testing and Imaging Contribute to the Early Diagnosis of Multiple System Atrophy? A Systematic Review and Recommendations by the Movement Disorder Society Multiple System Atrophy Study Group.

Authors:  Maria Teresa Pellecchia; Iva Stankovic; Alessandra Fanciulli; Florian Krismer; Wassilios G Meissner; Jose-Alberto Palma; Jalesh N Panicker; Klaus Seppi; Gregor K Wenning
Journal:  Mov Disord Clin Pract       Date:  2020-09-03

Review 5.  Optimizing Parkinson's disease diagnosis: the role of a dual nuclear imaging algorithm.

Authors:  J William Langston; Jesse C Wiley; Michele Tagliati
Journal:  NPJ Parkinsons Dis       Date:  2018-02-23

6.  Levodopa-responsive depression associated with corticobasal degeneration: a case report.

Authors:  Natsumi Tarakita; Haruo Nishijima; Norio Yasui-Furukori
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-18       Impact factor: 2.570

7.  Discriminative pattern of reduced cerebral blood flow in Parkinson's disease and Parkinsonism-Plus syndrome: an ASL-MRI study.

Authors:  Lina Cheng; Xiaoyan Wu; Ruomi Guo; Yuzhou Wang; Wensheng Wang; Peng He; Hanbo Lin; Jun Shen
Journal:  BMC Med Imaging       Date:  2020-07-13       Impact factor: 1.930

8.  Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson's disease.

Authors:  Anna Santaella; H Bea Kuiperij; Anouke van Rumund; Rianne A J Esselink; Alain J van Gool; Bastiaan R Bloem; Marcel M Verbeek
Journal:  NPJ Parkinsons Dis       Date:  2020-09-03

9.  Diagnostic challenges in multiple system atrophy.

Authors:  Diana Obelieniene; Sandra Bauzaite; Ilona Kulakiene; Evaldas Keleras; Indre Eitmonaite; Daiva Rastenyte
Journal:  Neuropsychiatr Dis Treat       Date:  2018-01-04       Impact factor: 2.570

10.  Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms.

Authors:  Anna Santaella; H Bea Kuiperij; Anouke van Rumund; Rianne A J Esselink; Alain J van Gool; Bastiaan R Bloem; Marcel M Verbeek
Journal:  BMC Neurol       Date:  2020-01-17       Impact factor: 2.474
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.